David Bourget (Western Ontario)
David Chalmers (ANU, NYU)
Rafael De Clercq
Jack Alan Reynolds
Learn more about PhilPapers
Cambridge Quarterly of Healthcare Ethics 5 (03):387- (1996)
Assume this hypothetical situation: an American pharmaceutical company, Maxwell Fisch Pharmaceuticals, Inc. , wishes to perform clinical trials involving a new antipsychotic medication, Klezac. Klezac is in its third phase of the clinical stage of the drug research process. Once the testing is complete, Maxwell plans to submit a New Drug Application, the official request to begin marketing Klezac, to the Food and Drug Administration . The new drug is expected to receive FDA approval in 2 or more years. The company decides to shift its research and development activities to Z, a small, developing country. In doing so, Maxwell is following the course taken by numerous other drug companies who wish to take advantage of faster governmental approval in foreign sites and ensuing cheaper research costs
|Keywords||No keywords specified (fix it)|
|Categories||categorize this paper)|
Setup an account with your affiliations in order to access resources via your University's proxy server
Configure custom proxy (use this if your affiliation does not provide a proxy)
|Through your library|
References found in this work BETA
No references found.
Citations of this work BETA
No citations found.
Similar books and articles
Jane L. Hutton & Richard E. Ashcroft (2000). Some Popular Versions of Uninformed Consent. Health Care Analysis 8 (1):41-53.
Emma Verástegui (2006). Consenting of the Vulnerable: The Informed Consent Procedure in Advanced Cancer Patients in Mexico. [REVIEW] BMC Medical Ethics 7 (1):1-12.
Piotr Zaborowski & Adam Górski (2004). Informed Consent and the Use of Placebo in Poland: Ethical and Legal Aspects. Science and Engineering Ethics 10 (1):167-178.
Peter R. Mansfield (2005). Banning All Drug Promotion is the Best Option Pending Major Reforms. Journal of Bioethical Inquiry 2 (2):75-81.
Sam K. Newton & John Appiah-poku (2007). The Perspectives of Researchers on Obtaining Informed Consent in Developing Countries. Developing World Bioethics 7 (1):19–24.
Stephen Wear (1999). Enhancing Clinician Provision of Informed Consent and Counseling: Some Pedagogical Strategies. Journal of Medicine and Philosophy 24 (1):34 – 42.
Min Liu & Qingli Hu (2014). A Proposed Approach to Informed Consent for Biobanks in China. Bioethics 28 (4):181-186.
Katherine Gehringer (2003). Informed Consent: Hospitals Must Obtain Informed Consent Prior to Drug Testing Pregnant Patients. Journal of Law, Medicine & Ethics 31 (3):455-457.
Deborah Bowman (2011). Informed Consent: A Primer for Clinical Practice. Cambridge University Press.
Sheila McLean (2010). Autonomy, Consent and the Law. Routledge-Cavendish.
Leonard J. Haas (1991). Hide-and-Seek or Show-and-Tell? Emerging Issues of Informed Consent. Ethics and Behavior 1 (3):175 – 189.
Piotr S. Iwanowski (2007). Informed Consent Procedure for Clinical Trials in Emergency Settings: The Polish Perspective. Science and Engineering Ethics 13 (3):333-336.
Augustine Frimpong-mansoh (2008). Culture and Voluntary Informed Consent in African Health Care Systems. Developing World Bioethics 8 (2):104-114.
Tom Walker (2011). Informed Consent and the Requirement to Ensure Understanding. Journal of Applied Philosophy 29 (1):50-62.
Added to index2010-08-24
Total downloads2 ( #511,927 of 1,699,829 )
Recent downloads (6 months)1 ( #362,609 of 1,699,829 )
How can I increase my downloads?